Test performance of faecal occult blood testing for the detection of bowel cancer in people with chronic kidney disease (DETECT) protocol
- Diagnosis of colorectal cancer from tissue sample passed per rectum. Wilson, Iain; Pancholi, Alok; Chan, Shirley // International Journal of Colorectal Disease;Aug2014, Vol. 29 Issue 8, p1021
A letter to the editor is presented that discusses the diagnosis of colorectal cancer from tissue sample passed per rectum.
- Chronic disease and assessing quality of life? Donnelly, Seamas C. // QJM: An International Journal of Medicine;Nov2016, Vol. 109 Issue 11, p701
No abstract available.
- Evaluating Rectal Bleeding. // Tufts University Health & Nutrition Letter;Dec2001, Vol. 19 Issue 10, p4
Reports a case study of a patient suffering from a colorectal cancer in the U.S. Symptoms of the disease; Importance of blood test in patients with colorectal cancer; Causes of rectal bleeding.
- Distribution of some activating KRAS and BRAF mutations in Slovene patients with colorectal cancer. Ličar, Alenka; Cerkovnik, Petra; Novaković, Srdjan; Ličar, Alenka; Novaković, Srdjan // Medical Oncology;Dec2011, Vol. 28 Issue 4, p1048
Numerous clinical studies have shown that anti-EGFR therapies are effective only in a subset of patients with colorectal cancer. Even though mutations in the KRAS gene have been confirmed as negative predictors of the response to EGFR-targeted therapies, not all KRAS wild-type (wt-KRAS) patients...
- Clear cell adenocarcinoma of the colon is a unique morphological variant of intestinal carcinoma: Case report with molecular analysis. Barisella, Marta; Lampis, Andrea; Perrone, Federica; Carbone, Antonino // World Journal of Gastroenterology;11/14/2008, Vol. 14 Issue 42, p6575
Here we report a new case of clear cell adenocarcinoma (CCA) of the colon in a 54-year-old Caucasian man. Despite of the previous reported cases, the lesion was located in the right colon and was not associated with the conventional adenoma. We performed immunohistochemical and molecular...
- Noninvasive Colon Check. Kozak, Diane; Harrar, Sari // Prevention;Jun2001, Vol. 53 Issue 6, p177
Reports on the development of a colon cancer test which measures abnormal DNA in cells found in stool samples.
- Delay in Seeking Advice for Symptoms that Potentially Indicate Bowel Cancer. Cockburn, Jill; Paul, Chris; Tzelepis, Flora; McElduff, Patrick; Byles, Julie // American Journal of Health Behavior;Jul/Aug2003, Vol. 27 Issue 4, p401
Objectives: To document knowledge, behavior and experiences of adults regarding potential signs and symptoms of bowel cancer. Methods: Telephone interviews with 1332 randomly selected adults, using similar questions to a survey conducted in 1988. Results: Twenty three percent (n=306) of...
- Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population. Wilson, Sue; Wakelam, Michael J. O.; Hobbs, Richard F. D.; Ryan, Angela V.; Dunn, Janet A.; Redman, Val D.; Patrick, Fiona; Colbourne, Lynne; Martin, Ashley; Ismail, Tariq // BMC Cancer;2006, Vol. 6, p258
Background: Bowel cancer is common and is a major cause of death. Meta-analysis of randomised controlled trials estimates that screening for colorectal cancer using faecal occult blood (FOB) test reduces mortality from colorectal cancer by 16%. However, FOB testing has a low positive predictive...
- Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study. Faivre, J; Tazi, M A; ElMrini, T; Lejeune, C; Benhamiche, A M; Dassonville, F // British Journal of Cancer;2/1/99, Vol. 79 Issue 3/4, p680
To estimate the efficacy of screening on colorectal cancer mortality, a population-based case-control study was conducted in well-defined areas of Burgundy (France). Screening by faecal occult blood test prior to diagnosis in cases born between 1914 and 1943 and who died of colorectal cancer...